Dennis H. Langer

Who is Dennis H. Langer?

Dr. Langer has served as a Managing Partner of Phoenix IP Ventures, a

venture capital firm, since August 2005. Prior to joining Phoenix IP

Ventures, he was President, North America, of Dr. Reddy’s Laboratories

Limited, an emerging global pharmaceutical company. Previously, Dr.

Langer was with GlaxoSmithKline for nine years. His last position at

GSK was Senior Vice President, Project and Portfolio Management. In

addition, Dr. Langer was responsible for Alliance Management and was a

member of the RD Executive Team. Prior to the merger of Glaxo

Wellcome and SmithKline Beecham, he was Senior Vice President, Product

Development Strategy and Senior Vice President, Research and

Development, Healthcare Services for SmithKline Beecham. He also held

management positions with Searle, Abbott, and Eli Lilly. Dr. Langer

served as the first President and Chief Executive Officer of Neose

Technologies, Inc. Dr. Langer earned an M.D. from Georgetown University

School of Medicine, a J.D. (cum laude) from Harvard Law School, and a

B.A. in Biology from Columbia University. Dr. Langer also serves on the

Boards of Myriad Genetics, Inc. and Cytogen Corporation, and is a

Clinical Professor, Department of Psychiatry, Georgetown University

School of Medicine.